Effects of intraovarian PRP, rFSH injection in poor ovarian responder

The effects of intraovarian platelet rich plasma and recombinant FSH injection on infertile women with poor ovarian response

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002576N33

Enrollment

Registered

2023-09-16

Start date

2023-09-23

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. N97.8

Interventions

Intervention 1: Intervention group:r FSH and platelet reach plasma that is prepared from patient s peripheral blood and injected in the ovarian tissue by transvaginal ultrasonographic guidance at the

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Abnormal ovarian reserve test. Antral follicle count<5. At least one previous IVF cycle <3oocyte was retrieved.

Exclusion criteria

Exclusion criteria: Ovarian insufficiency due to gonadal dysgenesia and abnormality of chromosoms Male infertility

Design outcomes

Primary

Measure	Time frame
FSH,LH,AMH,Esteradiol levels. Timepoint: Before and three months after intervention. Method of measurement: Laboratory tests.;Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Bhcg tests.;Number of MII oocyte. Timepoint: Three months after intervention. Method of measurement: Embryologist report.	—

Secondary

Measure	Time frame
Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Heart beat activity in transvaginal sonogram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavtanha@gmail.com0098218889800115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026